NORTH AMERICA CELLULITE TREATMENT MARKET FORECAST 2023-2032
The North America cellulite treatment market is projected to progress with a CAGR of 9.54% during the forecasted years of 2023-2032, acquiring a revenue share of $2053.22 million by 2032.
NORTH AMERICA CELLULITE TREATMENT MARKET FORECAST 2023-2032
North America Cellulite Treatment Market by Procedure (Non-invasive, Minimally Invasive, Topical) Market by Type (Soft Cellulite, Hard Cellulite, Edematous Cellulite) Market by End-user (Hospitals, Clinics and Beauty Centers, Other End-users) by Geography
The North America cellulite treatment market is projected to progress with a CAGR of 9.54% during the forecasted years of 2023-2032, acquiring a revenue share of $2053.22 million by 2032.
Some of the top factors propelling the market growth of the region include the presence of established market players and the strategic initiatives by these companies, in addition to the availability of a significant number of plastic surgeons. However, the North America cellulite treatment market may likely be hindered due to stringent regulations.
To know more about this report, request a free sample copy
The North America cellulite treatment market growth assessment comprises a detailed analysis of the United States and Canada. According to the Plastic Surgery Statistics Report, in 2020, around 86,350 cellulite treatment procedures were performed in the United States. Additionally, about 188,509 non-surgical skin tightening procedures, as well as 357,938 non-invasive fat reduction procedures, were performed in the country. The significant number is mainly credited to factors such as the high availability of plastic surgeons in the country, technological advancements, and increased disposable income. Hence, the surging number of cosmetic procedures in the United States is projected to play a vital role in augmenting the country’s cellulite treatment market growth.
On the other hand, as per a survey by the International Society of Aesthetic Plastic Surgery (ISAPS) 2021, the United States had one of the highest numbers of plastic surgeons, with an estimated 7,500 professionals in 2021. Furthermore, the surging prevalence of obesity in the United States is also set to augment the demand for cellulite treatments in the nation. As per the Centers for Disease Control and Prevention (CDC), the United States obesity prevalence was evaluated at more than 41% in March 2020. The growing numbers of obesity cases are projected to create notable opportunities for key players in the country. Therefore, these factors are expected to influence the cellulite treatment market growth in North America during the forecasted period.
The North America cellulite treatment market is segmented into procedure, type, and end-user. The procedure segment includes non-invasive, minimally invasive, and topical. Non-invasive procedures entail treatments that do not require the removal of tissue or incision into the body. For instance, cryolipolysis is a non-invasive procedure that freezes and destroys fat cells, which are then organically removed by the body. Likewise, several treatments utilize energy from ultrasound, radiofrequency, radial pulses, and infrared light to heat the skin, reduce cellulite, and stimulate collagen production.
Conversely, minimally invasive procedures include techniques that help limit the size of incisions required, thereby minimizing wound healing time, the risk of infection as well as associated pain. Subcision, for example, is a minimally invasive procedure where the doctor marks the target area, injects a numbing solution, and then inserts a small blade to cut the fat-holding connective tissue.
The top players operating in the North America cellulite treatment market are Johnson & Johnson, AbbVie Inc, Cutera Inc, etc.
Johnson & Johnson, headquartered in the United States, is involved in the sale and manufacture of a broad range of products in the healthcare field. The company’s business can be divided into three segments, namely pharmaceutical, consumer health, and medical devices. The consumer health segment includes products utilized in women’s health, skin health, baby care, and others.
The company’s Neutrogena Rapid Firming Collagen Triple Lift Face Serum hydrates and visibly firms the skin to restore a youthful and contoured-looking appearance.
Report Synopsis
|
Report Scope |
Details |
| Market Forecast Years | 2023-2032 |
| Base Year | 2022 |
| Market Historical Years | 2018-2022 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | Procedure, Type, End-User |
| Countries Analyzed | The United States and Canada |
| Companies Analyzed |
Johnson & Johnson, AbbVie Inc, Bausch Health Companies Inc, Cutera Inc, Inceler Medikal Co Ltd, Zimmer MedizinSysteme, Galderma SA, Sientra Inc, Endo International PLC, Candela Corporation, Nubway Co Ltd, Sinclair Pharma, Cynosure LLC, Merz Pharma GmbH & Co KGaA, Alma Lasers |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- SCOPE OF STUDY
- CRISIS SCENARIO ANALYSIS
- MAJOR MARKET FINDINGS
- RISING BEAUTY CONSCIOUSNESS
- GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
- RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
- RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY
- MARKET DYNAMICS
- KEY DRIVERS
- GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
- RISING CASES OF OBESITY
- RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
- KEY RESTRAINTS
- HIGH COST OF ADVANCED CELLULITE TREATMENT
- SIDE EFFECTS POST-TREATMENT
- LACK OF AWARENESS
- KEY DRIVERS
- KEY ANALYTICS
- PARENT MARKET ANALYSIS
- KEY TECHNOLOGY TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- GROWTH PROSPECT MAPPING
- MARKET MATURITY ANALYSIS
- MARKET CONCENTRATION ANALYSIS
- VALUE CHAIN ANALYSIS
- RESEARCH AND DEVELOPMENT
- PRODUCT DEVELOPMENT
- MARKETING AND DISTRIBUTION
- POST-SALES MONITORING
- KEY BUYING CRITERIA
- COST
- BRAND REPUTATION
- USABILITY
- MARKET BY PROCEDURE
- NON-INVASIVE
- MINIMALLY INVASIVE
- TOPICAL
- MARKET BY TYPE
- SOFT CELLULITE
- HARD CELLULITE
- EDEMATOUS CELLULITE
- MARKET BY END-USER
- HOSPITALS
- CLINICS AND BEAUTY CENTERS
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS
- NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES
- NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET
- COUNTRY ANALYSIS
- UNITED STATES
- UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- CANADA
- CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- UNITED STATES
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- ABBVIE INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- ALMA LASERS
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- BAUSCH HEALTH COMPANIES INC.
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- CANDELA CORPORATION
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- CUTERA INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- CYNOSURE LLC
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- ENDO INTERNATIONAL PLC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- GALDERMA SA
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- INCELER MEDIKAL CO LTD
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- JOHNSON & JOHNSON
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- MERZ PHARMA GMBH & CO KGAA
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- NUBWAY CO LTD
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- SIENTRA INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- SINCLAIR PHARMA
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- ZIMMER MEDIZINSYSTEME
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- ABBVIE INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT
TABLE 2: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 11: LEADING PLAYERS OPERATING IN NORTH AMERICA CELLULITE TREATMENT MARKET
TABLE 12: LIST OF ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022
FIGURE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 10: NORTH AMERICA CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 13: NORTH AMERICA CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 14: NORTH AMERICA CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 15: NORTH AMERICA CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 16: NORTH AMERICA CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 17: NORTH AMERICA CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 18: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)
FIGURE 19: NORTH AMERICA CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 21: UNITED STATES CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: CANADA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: ABBVIE INC COMPANY PROFIT 2017 – 2021 ($ BILLION)
FIGURE 24: ABBVIE INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 25: ABBVIE INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 26: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 – 2021 ($ BILLION)
FIGURE 27: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 28: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 29: CUTERA INC COMPANY PROFIT 2017 – 2021 ($ MILLION)
FIGURE 30: CUTERA INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 31: CUTERA INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 32: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 – 2021 ($ MILLION)
FIGURE 33: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 34: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 35: JOHNSON & JOHNSON COMPANY PROFIT 2017 – 2021 ($ BILLION)
FIGURE 36: JOHNSON & JOHNSON COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 37: JOHNSON & JOHNSON COMPANY REVENUE 2017 – 2021 ($ BILLION)
FIGURE 38: JOHNSON & JOHNSON COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 39: SIENTRA INC COMPANY PROFIT 2017 – 2021 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS
- NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES
- NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET
- COUNTRY ANALYSIS
- UNITED STATES
- UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- CANADA
- CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- UNITED STATES
- NORTH AMERICA
- MARKET BY PROCEDURE
- NON-INVASIVE
- MINIMALLY INVASIVE
- TOPICAL
- MARKET BY TYPE
- SOFT CELLULITE
- HARD CELLULITE
- EDEMATOUS CELLULITE
- MARKET BY END-USER
- HOSPITALS
- CLINICS AND BEAUTY CENTERS
- OTHER END-USERS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.